Ciccarelli, Nicoletta http://orcid.org/0000-0002-7582-9142
Fabbiani, Massimiliano
Brita, Anna C.
De Marco, Ramona
Grima, Pierfrancesco
Gagliardini, Roberta
Borghetti, Alberto
Cauda, Roberto
Di Giambenedetto, Simona
Article History
Received: 26 September 2018
Accepted: 14 February 2019
First Online: 19 February 2019
Compliance with ethical standards
:
: M. F. received speakers’ honoraria and support for travel to meetings from Bristol-Myers Squibb (BMS), Gilead, Merck Sharp & Dohme (MSD), ViiV Healthcare, Janssen-Cilag (JC), and fees for attending advisory boards from BMS and Gilead; A.B. reports personal fees and non-financial support from ViiV Healthcare, Gilead Sciences, Inc., grants and non-financial support from Bristol-Myers Squibb, and JC. R.C. has been an advisor for Gilead, JC and Basel Pharmaceutical, and received speakers’ honoraria from ViiV, BMS, MSD, Abbott, Gilead and JC; S. D. G. received speakers’ honoraria and support for travel to meetings from Gilead, Bristol-Myers Squibb (BMS), Abbott, Boehringer Ingelheim, Janssen-Cilag (JC) and GlaxoSmithKline. All other authors: none to declare.